Cochrane Abstracts
Intravenous immunoglobulin for Guillain‐Barré syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for Guillain‐Barré Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain‐Barré_syndrome.
Intravenous immunoglobulin for Guillain‐Barré syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain‐Barré_syndrome. Accessed October 30, 2025.
Intravenous immunoglobulin for Guillain‐Barré syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain‐Barré_syndrome
Intravenous Immunoglobulin for Guillain‐Barré Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 October 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain‐Barré_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for Guillain‐Barré syndrome
ID - 434987
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434987/all/Intravenous_immunoglobulin_for_Guillain‐Barré_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
